SANOFI (1SAN.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1SAN - FR0000120578 - Common Stock
87.71 EUR
-2.27 (-2.52%)
1SAN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. While 1SAN has a great profitability rating, there are some minor concerns on its financial health. 1SAN is not valued too expensively and it also shows a decent growth rate. 1SAN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
1SAN had positive earnings in the past year.
In the past year 1SAN had a positive cash flow from operations.
In the past 5 years 1SAN has always been profitable.
Each year in the past 5 years 1SAN had a positive operating cash flow.
1.2 Ratios
1SAN's Return On Assets of 11.05% is fine compared to the rest of the industry. 1SAN outperforms 74.07% of its industry peers.
The Return On Equity of 1SAN (19.73%) is better than 62.96% of its industry peers.
1SAN has a Return On Invested Capital of 13.84%. This is in the better half of the industry: 1SAN outperforms 66.67% of its industry peers.
1SAN had an Average Return On Invested Capital over the past 3 years of 7.31%. This is significantly below the industry average of 14.51%.
The last Return On Invested Capital (13.84%) for 1SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN has a better Profit Margin (20.35%) than 75.93% of its industry peers.
In the last couple of years the Profit Margin of 1SAN has grown nicely.
1SAN has a Operating Margin (23.59%) which is in line with its industry peers.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
Looking at the Gross Margin, with a value of 71.70%, 1SAN is in line with its industry, outperforming 51.85% of the companies in the same industry.
In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1SAN is creating some value.
Compared to 1 year ago, 1SAN has about the same amount of shares outstanding.
Compared to 5 years ago, 1SAN has about the same amount of shares outstanding.
The debt/assets ratio for 1SAN has been reduced compared to a year ago.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 2.21, which is a good value as it means it would take 1SAN, 2.21 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1SAN (2.21) is better than 79.63% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that 1SAN is not too dependend on debt financing.
The Debt to Equity ratio of 1SAN (0.21) is better than 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.79
WACC7.72%
2.3 Liquidity
1SAN has a Current Ratio of 1.27. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.27, 1SAN perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
1SAN has a Quick Ratio of 1.27. This is a bad value and indicates that 1SAN is not financially healthy enough and could expect problems in meeting its short term obligations.
1SAN has a Quick ratio (0.94) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for 1SAN have decreased by -5.35% in the last year.
Measured over the past 5 years, 1SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
The Revenue has been growing slightly by 2.56% in the past year.
1SAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.31% yearly.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
The Earnings Per Share is expected to grow by 7.06% on average over the next years.
The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.54, the valuation of 1SAN can be described as reasonable.
Based on the Price/Earnings ratio, 1SAN is valued a bit cheaper than the industry average as 79.63% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.45, 1SAN is valued rather cheaply.
The Price/Forward Earnings ratio is 10.21, which indicates a very decent valuation of 1SAN.
Based on the Price/Forward Earnings ratio, 1SAN is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
1SAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.54 | ||
| Fwd PE | 10.21 |
4.2 Price Multiples
1SAN's Enterprise Value to EBITDA is on the same level as the industry average.
1SAN's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.22 | ||
| EV/EBITDA | 11.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.76
PEG (5Y)2.26
EPS Next 2Y5.75%
EPS Next 3Y6.01%
5. Dividend
5.1 Amount
1SAN has a Yearly Dividend Yield of 4.59%, which is a nice return.
Compared to an average industry Dividend Yield of 3.01, 1SAN pays a better dividend. On top of this 1SAN pays more dividend than 88.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, 1SAN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
34.82% of the earnings are spent on dividend by 1SAN. This is a low number and sustainable payout ratio.
The dividend of 1SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
BIT:1SAN (11/18/2025, 7:00:00 PM)
87.71
-2.27 (-2.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap213.66B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target108.71 (23.94%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-2.32%
PT rev (3m)-1.72%
EPS NQ rev (1m)-3.95%
EPS NQ rev (3m)-6.91%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-4.9%
Revenue NQ rev (1m)-1.49%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.54 | ||
| Fwd PE | 10.21 | ||
| P/S | 3.15 | ||
| P/FCF | 21.22 | ||
| P/OCF | 18.77 | ||
| P/B | 3.05 | ||
| P/tB | 22.99 | ||
| EV/EBITDA | 11.25 |
EPS(TTM)7.6
EY8.66%
EPS(NY)8.59
Fwd EY9.79%
FCF(TTM)4.13
FCFY4.71%
OCF(TTM)4.67
OCFY5.33%
SpS27.87
BVpS28.74
TBVpS3.82
PEG (NY)3.76
PEG (5Y)2.26
Graham Number70.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.72%
ROIC/WACC1.79
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / 1SAN.MI FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 5 / 10 to 1SAN.MI.
What is the valuation status for 1SAN stock?
ChartMill assigns a valuation rating of 5 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (1SAN.MI) has a profitability rating of 7 / 10.
How financially healthy is SANOFI?
The financial health rating of SANOFI (1SAN.MI) is 4 / 10.
What is the earnings growth outlook for SANOFI?
The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 3.07% in the next year.